Overview

Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel

Status:
Not yet recruiting

Trial end date:
2020-12-16

Target enrollment:

Participant gender:

Summary

It will be performed a randomized, multicenter, triple-masked, placebo-controlled clinical experiment to determine the effectiveness and safety of the administration to of ivermectin at a dose of 200 mcg/kg once a week for 7 weeks in a prophylactic treatment against SARS COV-2 infection in 550 Colombian health workers during the COVID-19 pandemic.

Phase:

Phase 3

Details

Lead Sponsor:

Javeriana University

Treatments:

Ivermectin